MEGAN STEELY: Open Payments
NPI 1215041454 · TAYLORVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 53 payments from 15 companies in 2025. Trend: 2023 $668 · 2024 $747 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $136 |
| Novo Nordisk Inc | 7 | $124 |
| Lilly USA, LLC | 3 | $52 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Abbott Laboratories | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Viatris Specialty LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ABBVIE INC. | 1 | $23 |
Products named: REPATHA, Kerendia, Rybelsus, Wegovy, NEXLETOL, OTEZLA, FREESTYLE LIBRE 3, GEMTESA.
Industry payments across IL — which companies pay providers there.
